Pharmacy in Canada
Bookmark / Share
Email This

Communications with Government

It is crucial for pharmacists to be involved when governments are making decisions that affect our profession and the health and safety of Canadians. CPhA is dedicated to ensuring that pharmacists’ voices are heard. We communicate with all levels of government on a regular basis, submitting position statements, offering support and presenting to senate committees on issues that are important to you.

Parliamentary Committee Briefs

April 2014
Speaking notes to the House of Commons Standing Committee on Health
Official transcript of the proceedings, April 10, 2014
RE: Study of the Best Practices and Federal Barriers Related to the Scope of Practice and Skills Training of Healthcare Professionals

March 2014
Speaking notes to the Senate Committee on Social Affairs, Science and Technology
Official transcript of the proceedings, March 26, 2014
RE: Study on prescription pharmaceuticals in Canada — the nature of unintended consequences

December 2013
Speaking notes to the House of Commons Standing Committee on Health
Official transcript of the proceedings, December 2, 2013
RE: Prescription drug abuse

February 2013
Speaking notes to the Senate Committee on Social Affairs, Science, and Technology
Offical transcript of the proceedings, February 27, 2013
RE: Off-label use of prescription drugs

October 2011
Submission to the Senate Committee on Social Affairs, Science, and Technology
RE: Reviewing the 2004 Health Accord

October 2011
Submission to the House of Commons Standing Committee on Health
RE: Study on chronic disease and aging

August 2011
Submission to the House of Commons Finance Committee
RE: Pre-budget consultations

October 2010
Opening remarks and written brief to the Senate Committee on Social Affairs, Science and Technology
RE: The role of pharmacists in the H1N1 pandemic and recommendations on how to improve future pandemic

August 2010
Submission to the House of Commons Standing Committee on Finance
RE: Pre-budget consultations

May 2008
Submission to the House of Commons Standing Committee on Health (en français)
RE: Review of the 10-Year Plan to Strengthen Health Care

February 2008
Presentation to House of Commons Standing Committee on Health (en français)
RE: Post-market surveillance

March 2007
Joint submission to the US Senate Sub-Committee
RE: Cross-border prescription drug trade

Communications with Government

March 2013
RE: Alberta Government Cuts to Generic Drug Prices
             CPhA letter to Alberta Minister of Health re: Budget cuts to generic drug prices

March 2013
RE: Marihuana for Medical Purposes Regulations (MMPR) consultations
             CPhA's response to proposed Marihuana for Medical Purposes Regulations

May 2012
RE: Cancellation of supplemental health benefits under the Interim Federal Health Program
             Joint letter to Hon. Jason Kenney opposing cancellation of benefits

July 2011
RE: Medical Marihuana Consultations
            Comments to Health Canada on the consultation document "Proposed
            Improvements to Health Canada's Marihuana Medical Access Program"

December 2010
RE: Application of GST/HST to professional non-dispensing pharmacy services
            CPhA's request to Canada Revenue Agency for clarification of the issue
            Canada Revenue Agency's Response to CPhA

September 2010
RE: Pan-Canadian bulk purchasing arrangement for common drugs
            First Ministers’ announcement
            CPhA Response to Premiers (en français)
            CPhA Position Paper (2005)

July 2010
RE: Mandatory census long form
          Letter to Hon. Tony Clement

May 2010
RE: DIDFA
            CPhA Response to the Government of Ontario’s proposed regulatory changes to the
            Drug Interchangeability and Dispensing Fee Act

November 2006
RE: TDSPA
            Submission to the Ontario Ministry of Long Term Care
            Joint letter to Ontario Premier (CPhA, CACDS, CAPDM-Rx&D)

November 2006
RE: Cross-Border Prescription Drug Trade
            Joint letter to Hon. Tony Clement (CPhA, OPA, CAPDM, BMC)
            Joint Position Statement (CPhA, OPA, CAPDM, BMC)

November 2006
RE: Bill 41 – The Pharmaceutical Act
          CPhA Letter of Support